Research Review
The Number That Should Alarm You
A 2022 study published in the Journal of the American College of Cardiology by O'Hearn and colleagues analyzed data from over 55,000 US adults across two decades of the National Health and Nutrition Examination Survey. Their finding: as of 2018, only 6.8% of American adults met the criteria for optimal cardiometabolic health. Not 68%. Not 16.8%. Six point eight percent.
This means that more than 9 out of 10 adults in the United States have at least one cardiometabolic risk factor that is outside the optimal range. The majority have several. And the trend is getting worse, not better. Between 1999 and 2018, the proportion of adults with optimal metabolic health declined across every age group, every sex, and every racial and ethnic category studied.
The most unsettling part of this data is that most of the people captured in these statistics do not have a diagnosis. They are not diabetic. They have not had a heart attack. Their doctor may have told them their labs look "fine." But "fine" and "optimal" are very different standards, and the gap between them is where chronic disease develops.
The Five Markers of Metabolic Syndrome
Metabolic syndrome is defined by the presence of three or more of the following five criteria, as established by a joint statement from the International Diabetes Federation, the American Heart Association, and other bodies published in Circulation in 2009:
- Elevated waist circumference: greater than 40 inches (102 cm) for men or 35 inches (88 cm) for women
- Elevated triglycerides: 150 mg/dL or higher, or receiving treatment for elevated triglycerides
- Reduced HDL cholesterol: below 40 mg/dL for men or 50 mg/dL for women, or receiving treatment
- Elevated blood pressure: systolic 130 mmHg or higher, diastolic 85 mmHg or higher, or receiving antihypertensive treatment
- Elevated fasting glucose: 100 mg/dL or higher, or receiving treatment for elevated glucose
Having three of these five markers places you in the metabolic syndrome category, which significantly increases your risk for type 2 diabetes, cardiovascular disease, stroke, and several other chronic conditions. But even having one or two abnormal markers indicates that your metabolic health is suboptimal and warrants attention.
How Insulin Resistance Develops Silently
Insulin resistance is the central driver of metabolic dysfunction, and it develops over a timeline measured in years, not weeks. The process is gradual and almost entirely invisible to standard medical screening for much of its progression.
Here is the typical trajectory: your cells begin to respond less efficiently to insulin, often driven by excess visceral fat, chronic inactivity, poor sleep, or sustained stress. Your pancreas compensates by producing more insulin to force glucose into cells. For years, sometimes 10 to 15 years, this compensation keeps your fasting blood glucose in the normal range. Standard blood work comes back fine. But behind the scenes, your fasting insulin levels are climbing, your post-meal glucose spikes are getting higher and lasting longer, and your pancreas is working harder than it should.
This is why fasting insulin is a far better early marker than fasting glucose. Glucose stays normal until the compensatory mechanism fails. Insulin rises much earlier, often a decade before glucose becomes abnormal. Yet fasting insulin is rarely included in routine blood panels. If you want to know your metabolic status before problems become visible on standard labs, ask your doctor to test fasting insulin alongside fasting glucose and HbA1c.
What CGMs Reveal About Individual Glucose Responses
Continuous glucose monitors (CGMs) have given researchers and consumers a window into metabolic health that was previously invisible. A CGM measures interstitial glucose levels every few minutes, producing a continuous picture of how your body responds to food, exercise, stress, and sleep.
What CGM data consistently reveals is that glucose responses are highly individual. Two people can eat the same meal and produce dramatically different glucose curves. One person might spike to 160 mg/dL after eating white rice while another barely reaches 120 mg/dL. These differences are driven by gut microbiome composition, insulin sensitivity, muscle mass, sleep quality, stress levels, and dozens of other variables.
For people who are not diabetic but want to understand their metabolic health, CGMs provide actionable data that static blood tests cannot. They reveal which foods cause problematic spikes, how exercise timing affects glucose clearance, how sleep deprivation impairs insulin sensitivity the following day, and how stress produces glucose elevations even without eating. This kind of real-time feedback loop accelerates behavior change in ways that a quarterly blood panel never could.
The Connection to Chronic Disease
Metabolic dysfunction is not a standalone problem. It is a root cause, or at minimum a significant accelerant, of virtually every major chronic disease. The evidence connecting metabolic syndrome to disease risk is extensive:
- Cardiovascular disease: Metabolic syndrome doubles the risk of cardiovascular events and is present in the majority of heart attack patients.
- Type 2 diabetes: Metabolic syndrome increases the risk of developing type 2 diabetes by approximately fivefold.
- Cancer: A 2012 meta-analysis published in Diabetes Care found that metabolic syndrome was associated with significantly increased risk of liver, colorectal, and bladder cancers, among others.
- Alzheimer's disease: Insulin resistance in the brain is now considered a hallmark of Alzheimer's pathology. Some researchers have proposed calling it "type 3 diabetes."
- PCOS: Polycystic ovary syndrome has a strong bidirectional relationship with insulin resistance and metabolic dysfunction.
The throughline is clear: metabolic health is not one domain of wellness among many. It is foundational. When it degrades, risk rises across nearly every system in the body.
Exercise: The Most Powerful Intervention
The Diabetes Prevention Program (DPP), published in the New England Journal of Medicine in 2002, remains one of the most important clinical trials in metabolic health. The study enrolled 3,234 adults at high risk for type 2 diabetes and randomized them to one of three groups: a lifestyle intervention (150 minutes of moderate exercise per week plus a 7% body weight loss target), metformin medication, or a placebo.
The lifestyle intervention group reduced their incidence of type 2 diabetes by 58% compared to the placebo group. Metformin reduced it by 31%. Exercise-based lifestyle change was nearly twice as effective as medication. Follow-up studies have confirmed that these benefits persisted for at least 15 to 21 years.
Exercise improves metabolic health through multiple mechanisms. It increases glucose uptake by skeletal muscle independently of insulin (which is why a post-meal walk can flatten a glucose spike). It reduces visceral fat, which is the most metabolically dangerous fat depot. It improves mitochondrial function, reduces systemic inflammation, and increases insulin sensitivity for 24 to 48 hours after a single session.
Both resistance training and aerobic exercise contribute, but the combination is most effective. If you can only choose one intervention for metabolic health, choose movement. Track it, measure it, and build it into your daily routine. Vora integrates wearable data and activity tracking to help you monitor how your movement patterns affect your recovery and overall health trends.